Global Transplant Diagnostic Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 150
Status: Published
Report Code: ARI100924
Global Transplant Diagnostic Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Rising prevalence of chronic and infectious diseases, increasing awareness related to the transplant diagnostic procedures and growing R&D activities are some major factors driving the growth of Global Transplant Diagnostic Market.
Global Transplant Diagnostic Market is valued at USD 3.54 Billion in 2020 and expected to reach USD 5.80 Billion by 2027 with a CAGR of 7.3% over the forecast period.
Scope of Global Transplant Diagnostic Market Report
Transplant diagnostics are the tests led before movement/transplantation of the giver organ to recipient patient. HLA typing is one of most extreme significant applications, for example, organ and blood stem cell transplantation. Transplant diagnostics tests incorporate Human leukocyte antigen (HLA) diagnostic testing, PCR-based assay, serological test and blended lymphocyte culture (MLC) measure among others. Organ transplantation is a process where healthy organ from one person (alive/dead) is removed out and placed into recipient’s body (alive) that needs it for effective functioning of life. Organs that can be medically transplanted are kidneys, heart, lungs, intestine, liver, thymus and pancreas. Tissues that can be medically transplanted are bones, cornea, heart valves, veins, nerves, skin and tendons. Out of the entire most commonly transplanted organ is Kidney which is preceded by liver and then heart. Sir Peter Medawar is known as father of transplantation who worked on graft rejection and acquired immune tolerance in 1944 showed that skin allograft between two mice are rejected. On march 9th 1981 the first successful heart lung transplant took place at Stanford university hospital. The surgeon, Bruce Reitz, credited the patients recovery to cyclosporine-A.
The COVID-19 pandemic has shown a decline impact on the organ donation and transplantation in countries that have experienced high rates of infection. During COVID-19 pandemic, government imposed a restriction on transportation to reduce the risk of infection which pauses of elective surgeries in all specialties of medicine including the transplant diagnosis. Due to lockdown conditions and social distancing the transplant diagnostic were delayed or postponed. The imposition of lockdown measures urged the R&D personnel as well as clinical trials of the organizations various ways.
Global Transplant Diagnostic Market Segmentation:
Global transplant diagnostic market is segmented on the basis of technology, product & service, organ type, application, end-user and region & country level. Based upon technology, transplant diagnostic market is classified into molecular assay and non-molecular assay. Based upon product & service, the market is divided into reagents, instruments and software’s. Based on organ type, the transplant diagnostic market is classified into kidney, lungs, pancreas and heart. Based upon application, the market is divided into research and diagnostic. Based on organ end-user, the transplant diagnostic market is classified into hospital, research center, transplant center and commercial provider.
By Technology:
Molecular Assay
Non-molecular assay
By Product & Service:
Reagents
Instruments
Software’s
By Organ Type:
Kidney
Lungs
Pancreas
Heart
By Applications:
Research
Diagnostic
By End-User:
Hospital
Research center
Transplant center
Commercial provider
The regions covered in this global transplant diagnostic market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of transplant diagnostic is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players of Transplant diagnostic Market Report
Some major key players for global transplant diagnostic market report cover prominent players like Cylex Inc., Transonic, Stryker, LXN Corporation, Alpha Laboratories, Horiba Medical, Randox Laboratories Ltd, Thermo Fisher Scientific Inc., Otsuka Holdings Co Ltd., Medtronic, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Sanofi, Terumo Corporation, Preservation Solutions Inc., Laboratory Corporation of America Holdings, TransMedics Inc., AbbVie Inc., Zimmer Biomet, NHS Blood and Transplant and others.
News: Thermo Fisher Scientific Signed Partnership Agreement with the New Terasaki Innovation Center for Transplant Diagnostic Research
On October 29th, 2020; Thermo Fisher Scientific signed a partnership agreement with the recently formed Terasaki Innovation Center (TIC) to work with discovery and improvement of new pathways and devices to analyze and improved manage transplant patients. Thermo Fisher will have the principal choice to produce new advancements created by the TIC for use by clinicians, labs, and transplant centers all throughout the globe. Thermo Fisher's transplant diagnostics business is focused on improving the existences of patients worldwide by driving development and conveying quality products. The organization's inclusive item portfolio incorporates an expansive scope of antibody detection assays, post-transplant monitoring solutions including the novel Molecular Microscope Diagnostic System, HLA composing items, lab instrumentation and software, and industry-leading client support.
Rising Prevalence of Chronic and Infectious Diseases, Increasing Awareness Related to the Transplant Diagnostic Procedures and Growing R&D Activities are Some Major Factors Driving the Market Growth
Rising occurrence of chronic and infectious diseases is one of the major factors for driving the growth of global transplant diagnostic market. For instance; as indicated by WHO, in 2020, chronic diseases will represent right around three-quarters of all deaths around the world, and that 71% of deaths because of ischemic heart diseases (IHD), 75% of deaths because of stroke, and 70% of deaths because of diabetes will happen in developing nations. In addition, increasing awareness related to the transplant diagnostic procedures is another major factor supplementing the market growth. For example; according to US department of health and human services, 39,718 transfers were performed in 2019. Also, as indicated by HRSA, in excess of 113,000 individuals are in the waiting list for organ relocate in 2019. As per Health Resources and Services Administration, starting at 2019, each 10 minute an individual is being added to this waiting list for organ transfers.
Furthermore, growing R&D activities in this field are also fostering the growth of global transplant diagnostic market. For instance; in January 2020; the main American transplant diagnostics organization Eurofins Viracor presented its exclusive dd-cfDNA (contributor determined sans cell DNA) test, named Viracor TRAC. The new advancement is an expansion to the company’s wide-ranging collection of kidney transplant diagnostics.
However, high development cost of organ transplant and inappropriate values of the organ and surgery which may hamper the global transplant diagnostic market growth. In spite of that, development of advance technologies for successful organ transplant can offer more opportunities for the further growth of the global transplant diagnostic market over the forecast period.
North America Expected to Dominate the Global Transplant diagnostics Market
North America is expected to dominate the global transplant diagnostic market over the forecast period due to technological advancements, rising volume of organ transplantation procedures performed and presence of key players in this region. For instance; in February 2019, Care Dx dispatched the Allosure for lung transfers. According to Health Resources and Services Administration in 2019, the quantity of individuals requiring organ transplantation in the U.S. was 112,568, while the number of organ donor was pretty much as low as 19,267. Asia Pacific is expected to witness a fastest growth rate in the transplant diagnostic market over the forecast period due to the increasing chronic diseases, large patient population and improving healthcare infrastructure in this region.
North America
U.S.
Canada
Europe
U.K.
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Key Players/Companies
Cylex Inc., Transonic, Stryker, LXN Corporation, Alpha Laboratories, Horiba Medical, Randox Laboratories Ltd, Thermo Fisher Scientific Inc., Otsuka Holdings Co Ltd., Medtronic, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Sanofi, Terumo Corporation, Preservation Solutions Inc., Laboratory Corporation of America Holdings, TransMedics Inc., AbbVie Inc., Zimmer Biomet, NHS Blood and Transplant and others
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Transplant Diagnostic Market
Chapter 5. Global Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
5.1. Global Transplant Diagnostic Market Share, By Technology, 2015 - 2028 (USD Million)
5.1.1. Molecular Assay
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Non-molecular assay
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028(USD Million)
6.1. Global Transplant Diagnostic Market Share, By Product & Service, 2015 - 2028 (USD Million)
6.1.1. Reagents
6.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.2. Instruments
6.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.3. Software
6.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 7. Global Transplant Diagnostic Market Overview, By Organ Technology, 2015 - 2028(USD Million)
7.1. Global Transplant Diagnostic Market Share, By Organ Technology, 2015 - 2028 (USD Million)
7.1.1. Kidney
7.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.2. Lungs
7.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.3. Pancreas
7.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.4. Heart
7.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 8. Global Transplant Diagnostic Market Overview, By Applications, 2015 - 2028(USD Million)
8.1. Global Transplant Diagnostic Market Share, By Applications, 2015 - 2028 (USD Million)
8.1.1. Research
8.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
8.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
8.1.2. Diagnostic
8.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
8.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 9. Global Transplant Diagnostic Market Overview, By End-User, 2015 - 2028(USD Million)
9.1. Global Transplant Diagnostic Market Share, By End-User, 2015 - 2028 (USD Million)
9.1.1. Hospital
9.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
9.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
9.1.2. Research center
9.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
9.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
9.1.3. Transplant center
9.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
9.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
9.1.4. Commercial provider
9.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
9.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 10. Global Transplant Diagnostic Market Overview, By Geography, 2015 - 2028(USD Million)
10.1. Global Transplant Diagnostic Market Share, By Geography, 2015 - 2028(USD Million)
10.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
10.1.2. Market Share and CAGR Comparison, by Countries, 2021 - 2028 (%)
Chapter 11. North America Transplant Diagnostic Market Overview, By Countries, 2015 - 2028(USD Million)
11.1. North America Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. North America Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
11.1.3. North America Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
11.1.4. North America Transplant Diagnostic Market Overview, By Organ Technology,2015 - 2028 (USD Million)
11.1.5. North America Transplant Diagnostic Market Overview, By Applications,2015 - 2028 (USD Million)
11.1.6. North America Transplant Diagnostic Market Overview, By End-User,2015 - 2028 (USD Million)
11.1.7. North America Transplant Diagnostic Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1.7.1. U.S. Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
11.1.7.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.7.1.2. U.S. Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
11.1.7.1.3. U.S. Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
11.1.7.1.4. Other Segment
11.1.7.2. Canada Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
11.1.7.2.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.7.2.2. Canada Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
11.1.7.2.3. Canada Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
11.1.7.2.4. Other Segment
11.1.7.3. Mexico Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
11.1.7.3.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.7.3.2. Mexico Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
11.1.7.3.3. Mexico Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
11.1.7.3.4. Other Segment
Chapter 12. Europe Transplant Diagnostic Market Overview, By Countries, 2015 - 2028(USD Million)
12.1. Europe Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
12.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.2. Europe Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
12.1.3. Europe Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
12.1.4. Europe Transplant Diagnostic Market Overview, By Organ Technology,2015 - 2028 (USD Million)
12.1.5. Europe Transplant Diagnostic Market Overview, By Applications,2015 - 2028 (USD Million)
12.1.6. Europe Transplant Diagnostic Market Overview, By End-User,2015 - 2028 (USD Million)
12.1.7. Europe Transplant Diagnostic Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1.7.1. Germany
12.1.7.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.7.1.2. Germany Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
12.1.7.1.3. Germany Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028(USD Million)
12.1.7.1.4. Other Segments
12.1.7.2. France
12.1.7.2.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.7.2.2. France Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
12.1.7.2.3. France Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028(USD Million)
12.1.7.2.4. Other Segments
12.1.7.3. UK
12.1.7.3.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.7.3.2. UK Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
12.1.7.3.3. UK Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028(USD Million)
12.1.7.3.4. Other Segments
12.1.7.4. Italy
12.1.7.4.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.7.4.2. Italy Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
12.1.7.4.3. Italy Transplant Diagnostic Market Overview, By Product & Service2015 - 2028(USD Million)
12.1.7.4.4. Other Segments
12.1.7.5. Spain
12.1.7.5.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.7.5.2. Spain Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
12.1.7.5.3. Spain Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028(USD Million)
12.1.7.5.4. Other Segments
12.1.7.6. Rest of Europe
12.1.7.6.1. Market Size and projections, 2015 – 2027
12.1.7.6.2. Rest of Europe Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
12.1.7.6.3. Rest of Europe Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028(USD Million)
12.1.7.6.4. Other Segments
Chapter 13. Asia Pacific Transplant Diagnostic Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1. Asia Pacific Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
13.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.2. Asia Pacific Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
13.1.3. Asia Pacific Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
13.1.4. Asia Pacific Transplant Diagnostic Market Overview, By Organ Technology,2015 - 2028 (USD Million)
13.1.5. Asia Pacific Transplant Diagnostic Market Overview, By Applications,2015 - 2028 (USD Million)
13.1.6. Asia Pacific Transplant Diagnostic Market Overview, By End-User,2015 - 2028 (USD Million)
13.1.7. Asia Pacific Transplant Diagnostic Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1.7.1. India
13.1.7.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.1.2. India Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
13.1.7.1.3. India Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
13.1.7.1.4. Other Segments
13.1.7.2. China
13.1.7.2.1. Market Size and projections, 2015 - 2028(USD Million)
13.1.7.2.2. China Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
13.1.7.2.3. China Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
13.1.7.2.4. Other Segments
13.1.7.3. Japan
13.1.7.3.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.3.2. Japan Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
13.1.7.3.3. Japan Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028(USD Million)
13.1.7.3.4. Other Segments
13.1.7.4. South Korea
13.1.7.4.1. Market Size and projections, 2015 - 2028(USD Million)
13.1.7.4.2. South Korea Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
13.1.7.4.3. South Korea Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
13.1.7.4.4. Other Segments
13.1.7.5. Rest of Asia Pacific
13.1.7.5.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.5.2. Rest of Asia Pacific Transplant Diagnostic Market Overview, By Technology, 2015 - 2028(USD Million)
13.1.7.5.3. Rest of Asia Pacific Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
13.1.7.5.4. Other Segments
Chapter 14. Middle East & Africa Transplant Diagnostic Market Overview, By Countries, 2015 - 2028 (USD Million)
14.1. Middle East & Africa Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
14.1.1. Market Size and projections, 2015 - 2028 (USD Million)
14.1.2. Middle East & Africa Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
14.1.3. Middle East & Africa Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
14.1.4. Middle East & Africa Transplant Diagnostic Market Overview, By Organ Technology,2015 - 2028 (USD Million)
14.1.5. Middle East & Africa Transplant Diagnostic Market Overview, By Applications,2015 - 2028 (USD Million)
14.1.6. Middle East & Africa Transplant Diagnostic Market Overview, By End-User,2015 - 2028 (USD Million)
14.1.7. Middle East & Africa Transplant Diagnostic Market Overview, By Countries, 2015 - 2028 (USD Million)
14.1.7.1. GCC
14.1.7.1.1. Market Size and projections, 2015 - 2028 (USD Million)
14.1.7.1.2. GCC Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
14.1.7.1.3. GCC Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
14.1.7.1.4. Other Segments
14.1.7.2. South Africa
14.1.7.2.1. Market Size and projections, 2015 - 2028 (USD Million)
14.1.7.2.2. South Africa Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
14.1.7.2.3. South Africa Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
14.1.7.2.4. Other Segments
14.1.7.3. Rest of Middle East & Africa
14.1.7.3.1. Market Size and projections, 2015 - 2028 (USD Million)
14.1.7.3.2. Rest of Middle East & Africa Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
14.1.7.3.3. Rest of Middle East & Africa Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
14.1.7.3.4. Other Segments
Chapter 15. South America Transplant Diagnostic Market Overview, By Countries, 2015 - 2028 (USD Million)
15.1. South America Transplant Diagnostic Market Overview, 2015 - 2028 (USD Million)
15.1.1. Market Size and projections, 2015 - 2028 (USD Million)
15.1.2. South America Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
15.1.3. South America Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
15.1.4. South America Transplant Diagnostic Market Overview, By Organ Technology,2015 - 2028 (USD Million)
15.1.5. South America Transplant Diagnostic Market Overview, By Applications,2015 - 2028 (USD Million)
15.1.6. South America Transplant Diagnostic Market Overview, By End-User,2015 - 2028 (USD Million)
15.1.7. South America Transplant Diagnostic Market Overview, By Countries, 2015- 2026 (USD Million)
15.1.8. Brazil
15.1.8.1. Market Size and projections, 2015 - 2028 (USD Million)
15.1.8.2. Brazil Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
15.1.8.3. Brazil Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
15.1.8.4. Other Segments
15.1.9. Argentina
15.1.9.1. Market Size and projections, 2015 - 2028 (USD Million)
15.1.9.2. Argentina Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
15.1.9.3. Argentina Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
15.1.9.4. Other Segments
15.1.10. Rest of South America
15.1.10.1. Market Size and projections, 2015 – 2027
15.1.10.2. Rest of South America Transplant Diagnostic Market Overview, By Technology, 2015 - 2028 (USD Million)
15.1.10.3. Rest of South America Transplant Diagnostic Market Overview, By Product & Service, 2015 - 2028 (USD Million)
15.1.10.4. Other Segments
Chapter 16. Competitive Landscape
16.1. Competitive environment, 2021
16.2. Strategic framework
16.2.1. Partnership/agreement
16.2.2. Expansion
16.2.3. Mergers & Acquisitions
16.2.4. New Organ Technology development
Chapter 17. Key Vendor Analysis
17.1. Cylex Inc.
17.1.1. Company overview
17.1.2. Financial performance
17.1.3. Mice Benchmarking
17.1.4. Recent initiatives
17.1.5. SWOT analysis
17.2. Transonic
17.2.1. Company overview
17.2.2. Financial performance
17.2.3. Mice Benchmarking
17.2.4. Recent initiatives
17.2.5. SWOT analysis
17.3. Stryker
17.3.1. Company overview
17.3.2. Financial performance
17.3.3. Mice Benchmarking
17.3.4. Recent initiatives
17.4. LXN Corporation
17.5. Alpha Laboratories
17.6. Horiba Medical
17.7. Randox Laboratories Ltd
17.8. Thermo Fisher Scientific Inc.
17.9. Otsuka Holdings Co Ltd.
17.10. Medtronic
17.11. Other
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Transplant Diagnostic Market Industrial Chain Analysis
18.2. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Organ Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Organ Technology Progress in Related Size
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Transplant Diagnostic Market, 2015-2027 (USD Million)
4. Transplant Diagnostic requirement, by country, 2015-2027, (USD Million)
5. North America Transplant Diagnostic Market, By Technology, 2015-2027 (USD Million)
6. North America Transplant Diagnostic Market, By Product & Service, 2015-2027 (USD Million)
7. North America Transplant Diagnostic Market, By Organ Technology, 2015-2027 (USD Million)
8. North America Transplant Diagnostic Market, By Applications, 2015-2027 (USD Million)
9. North America Transplant Diagnostic Market, By End-User, 2015-2027 (USD Million)
10. Europe Transplant Diagnostic Market, By Technology, 2015-2027 (USD Million)
11. Europe Transplant Diagnostic Market, By Product & Service, 2015-2027 (USD Million)
12. Europe Transplant Diagnostic Market, By Organ Technology, 2015-2027 (USD Million)
13. Europe Transplant Diagnostic Market, By Applications, 2015-2027 (USD Million)
14. Europe Transplant Diagnostic Market, By End-User, 2015-2027 (USD Million)
15. Asia Pacific Transplant Diagnostic Market, By Technology, 2015-2027 (USD Million)
16. Asia Pacific Transplant Diagnostic Market, By Product & Service, 2015-2027 (Revenue, USD Million)
17. Asia Pacific Transplant Diagnostic Market, By Organ Technology, 2015-2027 (Revenue, USD Million)
18. Asia Pacific Transplant Diagnostic Market, By Applications, 2015-2027 (Revenue, USD Million)
19. Asia Pacific Transplant Diagnostic Market, By End-User, 2015-2027 (Revenue, USD Million)
20. Middle East & Africa Transplant Diagnostic Market, By Technology, 2015-2027 (USD Million)
21. Middle East & Africa Transplant Diagnostic Market, By Product & Service, 2015-2027 (USD Million)
22. Middle East & Africa Transplant Diagnostic Market, By Organ Technology, 2015-2027 (USD Million)
23. Middle East & Africa Transplant Diagnostic Market, By Applications, 2015-2027 (USD Million)
24. Middle East & Africa Transplant Diagnostic Market, By End-User, 2015-2027 (USD Million)
25. South America Transplant Diagnostic Market, By Technology, 2015-2027 (USD Million)
26. South America Transplant Diagnostic Market, By Product & Service, 2015-2027 (USD Million)
27. South America Transplant Diagnostic Market, By Organ Technology, 2015-2027 (USD Million)
28. South America Transplant Diagnostic Market, By Applications, 2015-2027 (USD Million)
29. South America Transplant Diagnostic Market, By End-User, 2015-2027 (USD Million)
30. Global Transplant Diagnostic Market, Company Market Share, 2021 - 2028 (%)
31. Cylex Inc. : Technology Benchmarking
32. Cylex Inc. : Financial Performance
33. Transonic : Technology Benchmarking
34. Transonic : Financial Performance
35. Stryker : Technology Benchmarking
36. Stryker : Financial Performance
37. LXN Corporation : Technology Benchmarking
38. LXN Corporation : Financial Performance
39. Alpha Laboratories : Technology Benchmarking
40. Alpha Laboratories : Financial Performance
41. Horiba Medical : Technology Benchmarking
42. Horiba Medical: Financial Performance
43. Randox Laboratories Ltd: Technology Benchmarking
44. Randox Laboratories Ltd: Financial Performance
45. Thermo Fisher Scientific Inc.: Technology Benchmarking
46. Thermo Fisher Scientific Inc.: Financial Performance
47. Otsuka Holdings Co Ltd.: Technology Benchmarking
48. Otsuka Holdings Co Ltd.: Financial Performance
49. Medtronic: Technology Benchmarking
50. Medtronic: Financial Performance
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Transplant Diagnostic Market share, By Technology, 2020 & 2027 (%)
10. Global Transplant Diagnostic Market share, by Molecular Assay, By Technology, 2015 - 2028 (USD Million)
11. Global Transplant Diagnostic Market share, by Non-molecular assay, By Technology, 2015 - 2028 (USD Million)
12. Global Transplant Diagnostic Market share, By Product & Service, 2020 & 2027 (%)
13. Global Transplant Diagnostic Market share, by Reagents, By Product & Service, 2015 - 2028 (USD Million)
14. Global Transplant Diagnostic Market share, by Instruments, By Product & Service 2015 - 2028 (USD Million)
15. Global Transplant Diagnostic Market share, by Software, By Product & Service 2015 - 2028 (USD Million)
16. Global Transplant Diagnostic Market share, By Organ Technology, 2020 & 2027 (%)
17. Global Transplant Diagnostic Market share, by Kidney, By Organ Technology, 2015 - 2028 (USD Million)
18. Global Transplant Diagnostic Market share, by Lungs, By Organ Technology 2015 - 2028 (USD Million)
19. Global Transplant Diagnostic Market share, by Pancreas, By Organ Technology 2015 - 2028 (USD Million)
20. Global Transplant Diagnostic Market share, by Heart, By Organ Technology 2015 - 2028 (USD Million)
21. Global Transplant Diagnostic Market Overview, By Applications, 2021 - 2028 (%)
22. Global Transplant Diagnostic Market share, by Research, By Applications 2015 - 2028 (USD Million)
23. Global Transplant Diagnostic Market share, by Diagnostic, By Applications 2015 - 2028 (USD Million)
24. Global Transplant Diagnostic Market Overview, By End-User, 2021 - 2028 (%)
25. Global Transplant Diagnostic Market share, by Hospital, By End-User 2015 - 2028 (USD Million)
26. Global Transplant Diagnostic Market share, by Research center, By End-User 2015 - 2028 (USD Million)
27. Global Transplant Diagnostic Market share, by Transplant center, By End-User 2015 - 2028 (USD Million)
28. Global Transplant Diagnostic Market share, by Commercial provider, By End-User 2015 - 2028 (USD Million)
29. Global Transplant Diagnostic Market share, by region, 2020 & 2027 (%)
30. Global Transplant Diagnostic Market share, by region, 2015 - 2028(USD Million)
31. North America Transplant Diagnostic Market, 2015 - 2028(USD Million)
32. North America Transplant Diagnostic Market share, by Countries, 2020 & 2027 (%)
33. U.S. Transplant Diagnostic Market, 2015 - 2028(USD Million)
34. Canada Transplant Diagnostic Market, 2015 - 2028(USD Million)
35. Mexico Transplant Diagnostic Market, 2015 - 2028(USD Million)
36. Europe Transplant Diagnostic Market, 2015 - 2028(USD Million)
37. Europe Transplant Diagnostic Market share, by Countries, 2020 & 2027 (%)
38. Spain Transplant Diagnostic Market, 2015 - 2028(USD Million)
39. UK Transplant Diagnostic Market, 2015 - 2028(USD Million)
40. Italy Transplant Diagnostic Market, 2015 - 2028(USD Million)
41. Germany Transplant Diagnostic Market, 2015 - 2028(USD Million)
42. France Transplant Diagnostic Market, 2015 - 2028(USD Million)
43. Rest of Europe Transplant Diagnostic Market, 2015 - 2028(USD Million)
44. Asia-Pacific Transplant Diagnostic Market, 2015 - 2028(USD Million)
45. Asia-Pacific Transplant Diagnostic Market share, by Countries, 2020 & 2027 (%)
46. China Transplant Diagnostic Market, 2015 - 2028(USD Million)
47. India Transplant Diagnostic Market, 2015 - 2028(USD Million)
48. Australia Transplant Diagnostic Market, 2015 - 2028(USD Million)
49. Japan Transplant Diagnostic Market, 2015 - 2028(USD Million)
50. Rest of Asia-Pacific Transplant Diagnostic Market, 2015 - 2028(USD Million)
51. Middle East & Africa Transplant Diagnostic Market, 2015 - 2028(USD Million)
52. Middle East & Africa Transplant Diagnostic Market share, by Countries, 2020 & 2027 (%)
53. GCC Transplant Diagnostic Market, 2015 - 2028(USD Million)
54. South Africa Transplant Diagnostic Market, 2015 - 2028(USD Million)
55. Rest Of Middle East & Africa Transplant Diagnostic Market, 2015 - 2028(USD Million)
56. South America Transplant Diagnostic Market, 2015 - 2028(USD Million)
57. Brazil Transplant Diagnostic Market, 2015 - 2028(USD Million)
58. Argentina Transplant Diagnostic Market, 2015 - 2028(USD Million)
59. Rest Of South America Transplant Diagnostic Market, 2015 - 2028(USD Million)
The Leading Key Players in Transplant Diagnostic Market 1
Abbott Laboratories
Becton, Dickinson and Company
Biomérieux SA
Bio-Rad Laboratories Inc.
CareDx
F Hoffman-La Roche AG
Hologic Inc.
Illumina Inc.
Qiagen NV
Thermo Fisher Scientific Inc.
